1. Home
  2. KORE vs CALC Comparison

KORE vs CALC Comparison

Compare KORE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • CALC
  • Stock Information
  • Founded
  • KORE 2003
  • CALC 2011
  • Country
  • KORE United States
  • CALC United States
  • Employees
  • KORE N/A
  • CALC N/A
  • Industry
  • KORE Telecommunications Equipment
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • CALC Health Care
  • Exchange
  • KORE Nasdaq
  • CALC Nasdaq
  • Market Cap
  • KORE 39.3M
  • CALC 22.9M
  • IPO Year
  • KORE N/A
  • CALC N/A
  • Fundamental
  • Price
  • KORE $2.30
  • CALC $1.61
  • Analyst Decision
  • KORE Hold
  • CALC Strong Buy
  • Analyst Count
  • KORE 2
  • CALC 3
  • Target Price
  • KORE $2.75
  • CALC $16.33
  • AVG Volume (30 Days)
  • KORE 8.1K
  • CALC 30.2K
  • Earning Date
  • KORE 08-14-2025
  • CALC 08-11-2025
  • Dividend Yield
  • KORE N/A
  • CALC N/A
  • EPS Growth
  • KORE N/A
  • CALC N/A
  • EPS
  • KORE N/A
  • CALC N/A
  • Revenue
  • KORE $282,254,000.00
  • CALC N/A
  • Revenue This Year
  • KORE $4.66
  • CALC N/A
  • Revenue Next Year
  • KORE $6.71
  • CALC N/A
  • P/E Ratio
  • KORE N/A
  • CALC N/A
  • Revenue Growth
  • KORE N/A
  • CALC N/A
  • 52 Week Low
  • KORE $1.10
  • CALC $1.42
  • 52 Week High
  • KORE $4.88
  • CALC $5.97
  • Technical
  • Relative Strength Index (RSI)
  • KORE 45.18
  • CALC 47.03
  • Support Level
  • KORE $2.23
  • CALC $1.42
  • Resistance Level
  • KORE $2.48
  • CALC $1.85
  • Average True Range (ATR)
  • KORE 0.20
  • CALC 0.15
  • MACD
  • KORE -0.01
  • CALC -0.00
  • Stochastic Oscillator
  • KORE 57.45
  • CALC 44.19

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: